Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Isis/AstraZeneca Expand Antisense Technology Collaboration
Yahoo/Zacks
Saturday, November 15, 2014 - 9:30am
tags:
AstraZeneca, Isis Pharmaceuticals, antisense, ISIS-STAT3Rx, hepatocellular carcinoma, prostate cancer, ISIS-ARRx
Federal judge has unsealed details in lawsuit filed by the city of Chicago against five makers of opioid painkillers
Bloomberg/Businessweek
Friday, November 14, 2014 - 11:07am
tags:
opioids, painkillers, chicago, Cephalon, Janssen, Endo Health Solutions, Teva Pharmaceutical
Boehringer taps WellPoint's outcomes data to develop new a-fib drugs
Fierce Biotech
Friday, November 14, 2014 - 11:03am
tags:
Boehringer Ingelheim, Wellpoint, atrial fibrillation, R&D, clinical outcomes
Johnson & Johnson (JNJ) Wins Label Expansion Approval For Antipsychotic Drug
Bidness Etc.
Friday, November 14, 2014 - 11:01am
tags:
JNJ, Janssen, antipsychotics, Invega Sustenna, schizophrenia
2015 an "important year" for Pfizer's IO pipeline, analysts say
Medical Marketing and Media
Friday, November 14, 2014 - 10:59am
tags:
Pfizer, immunotherapy
Belviq For Smoking Cessation - Sizzle Or Smolder?
Seeking Alpha
Friday, November 14, 2014 - 10:55am
tags:
Belviq, smoking cessation
AstraZeneca not only game in town for deal-hungry Pfizer
Yahoo/Reuters
Friday, November 14, 2014 - 10:47am
tags:
AstraZeneca, Pfizer, M&A, Actavis
Alnylam reports results from Phase 2 revusiran trial
Seeking Alpha
Friday, November 14, 2014 - 9:54am
tags:
Alnylam, revusiran, TTR cardiac amyloidosis, RNAi
Why are M&A hedge funds gun shy? Blame AbbVie for killing its Shire deal
Fierce Pharma
Friday, November 14, 2014 - 9:53am
tags:
M&A, AbbVie, Shire
Can Gilead Double From Here?
Forbes
Friday, November 14, 2014 - 9:51am
tags:
Gilead Sciences
FDA approves 2 new Allergan breast implants
Mass Device
Friday, November 14, 2014 - 9:49am
tags:
FDA, devices, Allergan, breast implants
Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community
Yahoo
Friday, November 14, 2014 - 9:29am
tags:
physicians, Allergan, M&A, Valeant Pharmaceuticals
Valeant Should Drop Allergan Bid And Go For Zoetis
Seeking Alpha
Friday, November 14, 2014 - 8:43am
tags:
Valeant Pharmaceuticals, Allergan, Zoetis, M&A
Can Actavis Break The Siege Of Allergan?
Forbes
Friday, November 14, 2014 - 8:27am
tags:
Actavis, Allergan, Valeant Pharmaceuticals, M&A
Are drug developers over-relying on genomics?
Fierce Biotech
Friday, November 14, 2014 - 8:00am
tags:
R&D, genomics
Bristol-Myers Squibb to Construct a New Large-Scale Biologics Manufacturing Facility in Cruiserath, Ireland
Yahoo
Friday, November 14, 2014 - 7:57am
tags:
Bristol-Myers Squibb, drug manufacturing
Vascular Solutions and CEO indicted on charges of conspiracy and selling an unapproved device
Bizjournals.com
Thursday, November 13, 2014 - 7:21pm
tags:
Vascular Solutions, conspiracy, devices, off-label
Veracyte misses 3Q net income and revenue expectations
Yahoo/AP
Thursday, November 13, 2014 - 7:17pm
tags:
Veracyte, earnings
Puma Biotech says cancer drug fails mid-stage study
Yahoo/Reuters
Thursday, November 13, 2014 - 7:16pm
tags:
Puma Biotechnology, breast cancer, neratinib
Geron sells last drug in pipeline to J&J unit
Yahoo/Reuters
Thursday, November 13, 2014 - 7:14pm
tags:
Geron, JNJ, imetelstat, Jakafi, myelofibrosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.